Stocks · News reference

Envoy Medical Announces Delaware Chancery Court Dismissal With Prejudice Of Atlas Merchant Capital Spac Fund I's Claim That It Was Not Allowed To Redeem Shares

Oct 7, 2026, 1:06 PMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaOct 12, 2026, 12:33 PMBenzinga Newsdesk
Envoy Medical Submits Second FDA Module Of Its PMA Application For The Acclaim Cochlear Implant; Targets Final Clinical Submission In Q2 2027
Second of Four Planned Modules Moves Rolling FDA Review ForwardAdvances Toward Targeted Completion of the Final Clinical Module Submission in Q2 2027White Bear Lake, Minnesota--(Newsfile Corp. - October 12, 2026) -
COCH
BenzingaOct 6, 2026, 7:56 PMBenzinga Newsdesk
Lake Street Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $2.5
Lake Street analyst Frank Takkinen initiates coverage on Envoy Medical (NASDAQ:COCH) with a Buy rating and announces Price Target of $2.5.
COCH
BenzingaSep 22, 2026, 12:35 PMBenzinga Newsdesk
Envoy Medical Granted Two Additional Global Patents Over Its IP Portfolio
Envoy Medical® Inc. (NASDAQ:COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced the grant of two additional international
COCH